In 1999, with generous support from the Arthur and Rochelle Belfer Foundation, the Belfer Center for Cancer Genomics was founded. The Center initially focused on developing high-resolution platforms and computational tools for global genomic profiling of DNA abnormalities in human cancers. The center also established a robust pipeline for high-throughput genomic analyses of human and mouse tumors, and became one of The Cancer Genome Atlas’ select Cancer Genome Characterization Centers during its Pilot Phase (2006-2009).
In 2004, the Center for Applied Cancer Science at Dana-Farber Cancer Institute was established, designed to bring together the best attributes of academia and industry to rapidly translate cancer genomics knowledge into more effective cancer therapies. In 2006, with a visionary commitment from the Robert A. and Renée E. Belfer Foundation, the Belfer Center for Cancer Genomics and the Center for Applied Cancer Science became the Robert A. and Renée E. Belfer Institute for Applied Cancer Science.
In 2015, thanks to another transformational gift from the Belfers, the Belfer Center moved into the Longwood Center, a new state-of-the-art research facility. There, Belfer Center scientists are working alongside renowned Dana-Farber chemists and biologists to accelerate the pace of novel drug discovery and deliver new treatments to cancer patients faster.
This most recent gift brings the Belfers’ total giving to Dana-Farber to more than $25 million.